Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2020

01-12-2020 | Computed Tomography | Research article

The value of bronchial and cavity contraction rates in differentiating benign and malignant pulmonary cavities

Authors: Hua Zhang, Xia Qian, Zheng-Hua Liu, Yi Gong

Published in: BMC Pulmonary Medicine | Issue 1/2020

Login to get access

Abstract

Background

The present study aimed to assess the value of bronchial and cavity contraction percentages in differentiating benign and malignant pulmonary cavities.

Methods

Forty-two patients with pulmonary cavities were scanned by dual-phase computed tomography (CT). Then, the cavity and bronchial contraction percentages were respectively measured, the differences between the benign and malignant cavities were compared, and the best diagnostic critical point for differentiating benign and malignant cavities was obtained through the receiver operator characteristic (ROC) curve of the diagnostic test.

Results

The contraction percentage of the bronchial end with benign cavities was significantly higher than that of the bronchial end with malignant cavities (P < 0.001). The contraction percentage was significantly higher in the benign group than in the malignant group (P < 0.001). The ROC analysis revealed that the sensitivity and specificity of the bronchial contraction percentage was 90.50 and 86.40%, respectively, while the sensitivity and specificity of the cavity contraction percentage was 90.50 and 90.90%, respectively.

Conclusion

The dual-phase CT scanning of the bronchial and cavity contraction percentage can distinguish between benign and malignant cavities.
Literature
1.
go back to reference Tomizawa K, Shimizu S, Ohara S, Fujino T, Nishino M, Sesumi Y, et al. Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancer. Lung Cancer. 2017;112:57–61.CrossRef Tomizawa K, Shimizu S, Ohara S, Fujino T, Nishino M, Sesumi Y, et al. Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancer. Lung Cancer. 2017;112:57–61.CrossRef
2.
go back to reference Gadkowski LB, Stout JE. Cavitary pulmonary disease. Clin Microbiol Rev. 2008;21:305–33.CrossRef Gadkowski LB, Stout JE. Cavitary pulmonary disease. Clin Microbiol Rev. 2008;21:305–33.CrossRef
3.
go back to reference Takeuchi K, Hayakawa N, Oouchi M. Lung Cancer with multiple cavitation and ground glass opacity;report of a case. Kyobu Geka. 2017;70:477–9.PubMed Takeuchi K, Hayakawa N, Oouchi M. Lung Cancer with multiple cavitation and ground glass opacity;report of a case. Kyobu Geka. 2017;70:477–9.PubMed
4.
go back to reference Zhao J, Zheng BX, Guo QL. Spiral CT in diagnosis and classification of pulmonary tuberculosis. Chin J Med Imaging Technol. 2006;22:741–4. Zhao J, Zheng BX, Guo QL. Spiral CT in diagnosis and classification of pulmonary tuberculosis. Chin J Med Imaging Technol. 2006;22:741–4.
5.
go back to reference Mortensen KH, Babar JL, Balan A. Multidetector CT of pulmonary cavitation: filling in the holes. Clin Radiol. 2015;70:446–56.CrossRef Mortensen KH, Babar JL, Balan A. Multidetector CT of pulmonary cavitation: filling in the holes. Clin Radiol. 2015;70:446–56.CrossRef
6.
go back to reference Kobashi Y, Fukuda M, Nakata M, Oka M. Coexistence of metastatic lung cancet and pulmonary tuberculosis diagnosed in the same cavity. Int J Clin Oncol. 2005;10:366–70.CrossRef Kobashi Y, Fukuda M, Nakata M, Oka M. Coexistence of metastatic lung cancet and pulmonary tuberculosis diagnosed in the same cavity. Int J Clin Oncol. 2005;10:366–70.CrossRef
7.
go back to reference Kunihiro Y, Kobayashi T, Tanaka N, Matsumoto T, Okada M, Kamiya M, et al. High-resolution CT findings of primary lung cancer with cavitation: a comparison between adenocarcinoma and squamous cell carcinoma. Clin Radiol. 2016;71:1126–31.CrossRef Kunihiro Y, Kobayashi T, Tanaka N, Matsumoto T, Okada M, Kamiya M, et al. High-resolution CT findings of primary lung cancer with cavitation: a comparison between adenocarcinoma and squamous cell carcinoma. Clin Radiol. 2016;71:1126–31.CrossRef
8.
go back to reference Opoka LM. CT imaging features of thin-walled cavitary squamous cell lung cancer. Adv Respir Med. 2019;87:114–7.CrossRef Opoka LM. CT imaging features of thin-walled cavitary squamous cell lung cancer. Adv Respir Med. 2019;87:114–7.CrossRef
9.
go back to reference Masuhiro K, Shiroyama T, Nagatomo I, Kumanogoh A. Unique case of Pseudopro- gression manifesting as LungCavitation after Pembrolizumab treatment. J Thorac Oncol. 2019;14:e108–9.CrossRef Masuhiro K, Shiroyama T, Nagatomo I, Kumanogoh A. Unique case of Pseudopro- gression manifesting as LungCavitation after Pembrolizumab treatment. J Thorac Oncol. 2019;14:e108–9.CrossRef
10.
go back to reference Pistolesi M, Camiciottoli G, Paoletti M, Marmai C, Lavorini F, Meoni E, et al. Identification of apredominant COPD phenotype in clinical practice. Respir Med. 2008;102:367–9.CrossRef Pistolesi M, Camiciottoli G, Paoletti M, Marmai C, Lavorini F, Meoni E, et al. Identification of apredominant COPD phenotype in clinical practice. Respir Med. 2008;102:367–9.CrossRef
11.
go back to reference Rennard SI. Chronic obstructive pulmonary disease:linking outcomes and pathobiology of disease modification. Proc Am Thorac Soc. 2006;3:276–8.CrossRef Rennard SI. Chronic obstructive pulmonary disease:linking outcomes and pathobiology of disease modification. Proc Am Thorac Soc. 2006;3:276–8.CrossRef
12.
go back to reference Cho MH, Washko GR, Hoffmann TJ, Criner GJ, Hoffman EA, Martinez FJ, et al. Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respir Res. 2010;11:30–3.CrossRef Cho MH, Washko GR, Hoffmann TJ, Criner GJ, Hoffman EA, Martinez FJ, et al. Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respir Res. 2010;11:30–3.CrossRef
13.
go back to reference Nguyen NC, Abhishek K, Nyon S, Farghaly HR, Osman MM, Reimers HJ. Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lungcarcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study. Ann Thorac Med. 2016;11:49–54.CrossRef Nguyen NC, Abhishek K, Nyon S, Farghaly HR, Osman MM, Reimers HJ. Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lungcarcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study. Ann Thorac Med. 2016;11:49–54.CrossRef
14.
go back to reference Gafoor K, Patel S, Girvin F, Gupta N, Naidich D, Machnicki S, et al. Cavitary lung diseases: a clinical-radiologic algorithmic approach. Chest. 2018;153:1443–65.CrossRef Gafoor K, Patel S, Girvin F, Gupta N, Naidich D, Machnicki S, et al. Cavitary lung diseases: a clinical-radiologic algorithmic approach. Chest. 2018;153:1443–65.CrossRef
15.
go back to reference Nakao M, Muramatsu H, Arakawa S, Sakai Y, Suzuki Y, Fujita K, et al. Immun- onutritional status and pulmonary cavitation in patients with tuberculosis: a revisit with an assessment of neutrophil/lymphocyte ratio. Respir Investig. 2019;57:60–6.CrossRef Nakao M, Muramatsu H, Arakawa S, Sakai Y, Suzuki Y, Fujita K, et al. Immun- onutritional status and pulmonary cavitation in patients with tuberculosis: a revisit with an assessment of neutrophil/lymphocyte ratio. Respir Investig. 2019;57:60–6.CrossRef
16.
go back to reference Felix L, Lantuejou S, Jankowski A, Ferretti G. Localized pure or mixed ground-glass lung opacities. J Radiol. 2009;90:1869–92.CrossRef Felix L, Lantuejou S, Jankowski A, Ferretti G. Localized pure or mixed ground-glass lung opacities. J Radiol. 2009;90:1869–92.CrossRef
17.
go back to reference Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–4.CrossRef Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–4.CrossRef
18.
go back to reference Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, et al. Quantitative assessment of emphysema , air trapping, and airway thickening on computed tomography. Lung. 2008;186:157–9.CrossRef Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, et al. Quantitative assessment of emphysema , air trapping, and airway thickening on computed tomography. Lung. 2008;186:157–9.CrossRef
19.
go back to reference Matsuoka S, Kurihara Y, Yagihashi K, Hoshino M, Nakajima Y. Airway dimensions at inspiratory and expiratory multisention CT in chronic obstructive pulmonary disease: correlation with airflow limitation. Radiology. 2008;248:1042–9.CrossRef Matsuoka S, Kurihara Y, Yagihashi K, Hoshino M, Nakajima Y. Airway dimensions at inspiratory and expiratory multisention CT in chronic obstructive pulmonary disease: correlation with airflow limitation. Radiology. 2008;248:1042–9.CrossRef
Metadata
Title
The value of bronchial and cavity contraction rates in differentiating benign and malignant pulmonary cavities
Authors
Hua Zhang
Xia Qian
Zheng-Hua Liu
Yi Gong
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2020
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-020-01238-z

Other articles of this Issue 1/2020

BMC Pulmonary Medicine 1/2020 Go to the issue